ctDNA in Early Breast Cancer: Prognostic Power vs Clinical Actionability
Circulating tumor DNA helps detect minimal residual disease and predict recurrence risk in early breast cancer, but its role in guiding treatment decisions remains promising yet unproven.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.